EUVIMEDEUVIMED entdecken
Crossref

Dexmedetomidine Stimulates Cellular Senescence of Lung Cancer Cells Via NOX5

Dongcheng Zhang, Wei Liang, Zigang Li, Dongbo Chen, Jun Jiang, Yusheng Li, Fan Wang iD

Journal of Biochemical and Molecular Toxicology · 2025

DOI: 10.1002/jbt.70414 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Biochemical and Molecular Toxicology, 2025. Verfasst von Dongcheng Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei City, China. Hauptthemen laut MEDLINE: Cellular Senescence, Dexmedetomidine, Lung Neoplasms, NADPH Oxidase 5. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Gefördert von: This study was supported by the First Affiliated Hospital of Anhui Medical University..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Dexmedetomidine is a highly selective α‐ 2 adrenergic receptor agonist which has been considered as a promising anticancer agent. However, the underlying molecular mechanisms whereby Dexmedetomidine exerts its anticancer and chemopreventive actions need to be elucidated. In this study, we found that Dexmedetomidine reduced cell viability of the lung cancer cell line A549 cells in a dose‐dependent manner. Importantly, Dexmedetomidine reduced the telomerase activity in A549 cells by reducing the gene levels of hTERT but increasing the gene levels of TERF2. The senescence‐ associated‐β‐ galactosidase (SA‐β‐Gal) staining assay demonstrates that Dexmedetomidine stimulated cellular senescence by activating the p53/p16 signaling. Additionally, treatment with Dexmedetomidine led to increased ROS production and the expression of γH2AX, implicating typical DNA damage in lung cancer cells. Interestingly, Dexmedetomidine increased the expression of NOX5 but not NOX1 or NOX2. Knockdown of NOX5 abolished the effects of Dexmedetomidine in telomerase activity, gene expression of hTERT and TERF2, the p53/p16 signaling, as well as cellular senescence, suggesting that the effects of Dexmedetomidine are mediated by NOX5. In summary, these findings show that Dexmedetomidine blunts the growth of lung cancer cells by inducing premature senescence via ROS‐mediated DNA damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescenceDexmedetomidineLung NeoplasmsNADPH Oxidase 5Neoplasm ProteinsHumansA549 CellsReactive Oxygen SpeciesDNA DamageTelomeraseSignal TransductionTumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p16

Stichwörter der Autor:innen

DNA damageROSdexmedetomidinelung cancersenescence

Substanzen

DexmedetomidineReactive Oxygen SpeciesNADPH Oxidase 5NOX5 protein, humanTelomeraseTumor Suppressor Protein p53Cyclin-Dependent Kinase Inhibitor p16Neoplasm ProteinsTERT protein, humanCDKN2A protein, human

Autor:innen und Institutionen

  • Department of Radiation Oncology, The First Affiliated Hospital of Anhui Medical University, Hefei City, China.
  • Peking University Shenzhen Graduate School, Shenzhen City, China.

ORCID-Profile: Fan Wang

Förderung

  • This study was supported by the First Affiliated Hospital of Anhui Medical University.

Zitieren

APA

Zhang, D., Liang, W., Li, Z., Chen, D., Jiang, J., Li, Y., & Wang, F. (2025). Dexmedetomidine Stimulates Cellular Senescence of Lung Cancer Cells Via NOX5. Journal of Biochemical and Molecular Toxicology. https://doi.org/10.1002/jbt.70414

Vancouver

Zhang D, Liang W, Li Z, Chen D, Jiang J, Li Y, et al. Dexmedetomidine Stimulates Cellular Senescence of Lung Cancer Cells Via NOX5. Journal of Biochemical and Molecular Toxicology. 2025. doi:10.1002/jbt.70414

BibTeX
@article{Zhang2025,
  author = {Zhang, Dongcheng and Liang, Wei and Li, Zigang and Chen, Dongbo and Jiang, Jun and Li, Yusheng and Wang, Fan},
  title = {Dexmedetomidine Stimulates Cellular Senescence of Lung Cancer Cells Via NOX5},
  journal = {Journal of Biochemical and Molecular Toxicology},
  year = {2025},
  doi = {10.1002/jbt.70414}
}
Kostenlos starten →